![3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives](/docs/US/2021-08-19/US20210251996A1/abs.jpg.600x600.jpg)
- 专利标题： 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives
-
申请号： US16981208申请日： 2019-03-25
-
公开(公告)号： US20210251996A1公开(公告)日： 2021-08-19
- 发明人: Luca Arista , Christina Hebach , Gregory John Hollingworth , Philipp Holzer , Patricia Imbach-Weese , Rainer Machauer , Niko Schmiedeberg , Anna Vulpetti , Thomas Zoller
- 申请人： NOVARTIS AG
- 申请人地址： CH Basel
- 专利权人： NOVARTIS AG
- 当前专利权人： NOVARTIS AG
- 当前专利权人地址： CH Basel
- 优先权： EP18164085.5 20180326
- 国际申请： PCT/IB2019/052392 WO 20190325
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; C07D519/00 ; C07D487/04 ; A61P35/00
![3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives](/abs-image/US/2021/08/19/US20210251996A1/abs.jpg.150x150.jpg)
摘要：
The invention relates to compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.
公开/授权文献
信息查询
IPC分类:
